About Maps Laboratories
Maps Laboratories is a Healthcare company based in Rajkot (India). Manufacturing and exporting of pharmaceutical bulk drugs and formulations in India. Its Indian entity Maps Laboratories Private Limited reported revenue of ₹34.03 Cr. Maps Laboratories offers products and services including Gabapentin and Pregabalin. Its focus areas include Pharmaceuticals, API Manufacturing, Bulk Drugs and Formulation Products.
Company details
Maps Laboratories was established in 1999 and is engaged in the manufacturing and exporting of a wide range of bulk drugs and formulation products, including Gabapentin and Pregabalin. It is recognized for its qualitative Active Pharmaceutical Ingredients, with operations led under the direction of Mr. Rupesh Patel as CEO. A mission to provide innovative APIs for global healthcare is pursued, along with a vision for high-quality production that adheres to ethical standards. Manufacturing occurs across multiple plants in Gujarat, India, focusing on contributions to healthcare through research-based excellence. Client feedback highlights practical tools and methods offered by the company.
- Headquarters Rajkot, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Maps Laboratories Pvt. Ltd
- Date of Incorporation 28 Aug, 2001
- Jurisdiction Rajkot, Gujarat, India
- Annual Revenue₹34.03 Cr
FY 2024 · -25% YoY
- Net Profit₹23.5 Lakh
FY 2024 · 1% margin
- EBITDA₹1.04 Cr
FY 2024 · 3% margin
Associated legal entities of Maps Laboratories
Maps Laboratories operates through Maps Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Maps Laboratories Private Limited CIN U24117GJ2001PTC039923 | Active | 28 Aug 2001 | Rajkot, Gujarat | ₹34.0 Cr | 2 | View details |
Products & Services of Maps Laboratories
Maps Laboratories offers a comprehensive portfolio of products and services, including Gabapentin and Pregabalin.
Gabapentin is manufactured as a bulk drug and formulation product for pharmaceutical applications.
Pregabalin is produced as part of the range of bulk drugs and intermediates for medical uses.
Board of directors of Maps Laboratories Private Limited (Maps Laboratories)
Maps Laboratories Private Limited is the primary company behind Maps Laboratories. The board of Maps Laboratories Private Limited currently have 2 directors; the longest-serving is Rupeshkumar Maganlal Kotadia, appointed in 2001. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rupeshkumar Maganlal Kotadia DIN 01120189 | Director | 28 Aug 2001 | 25 yrs 1 mo | Maps Laboratories Private Limited |
| Krunalbhai Jayantilal Kotadiya DIN 02365870 | Director | 10 Oct 2008 | 18 yrs | Maps Laboratories Private Limited |
Financials of Maps Laboratories
Figures of Maps Laboratories Private Limited, the primary company behind Maps Laboratories, for FY 2024. Revenue was ₹34.03 Cr (-25% year on year). Net profit was ₹23.5 Lakh (1% margin). EBITDA was ₹1.04 Cr (3% margin). Revenue has grown at a compounded annual rate of -5% over three years and +4% over five years.
- ₹34.03 CrRevenue · FY 2024 · -25% YoY
- ₹23.5 LakhNet profit · 1% margin
- ₹1.04 CrEBITDA · 3% margin
- ₹1.50 CrPaid-up capital
- -5%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Maps Laboratories Private Limited are on its company page.
Detailed financial statements for Maps Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Maps Laboratories
Maps Laboratories is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.
The primary company behind Maps Laboratories, Maps Laboratories Private Limited, reported revenue of ₹34.03 Cr for FY 2024, down 25% year on year.
Maps Laboratories was established in 1999 and is engaged in the manufacturing and exporting of a wide range of bulk drugs and formulation products, including Gabapentin and Pregabalin. It is recognized for its qualitative Active Pharmaceutical Ingredients, with operations led under the direction of Mr. Rupesh Patel as CEO. A mission to provide innovative APIs for global healthcare is pursued, along with a vision for high-quality production that adheres to ethical standards. Manufacturing occurs across multiple plants in Gujarat, India, focusing on contributions to healthcare through research-based excellence. Client feedback highlights practical tools and methods offered by the company.
Maps Laboratories offers Gabapentin and Pregabalin.
Maps Laboratories operates through Maps Laboratories Private Limited.
The legal entities of Maps Laboratories currently have 2 directors, including Krunalbhai Jayantilal Kotadiya, Rupeshkumar Maganlal Kotadia.